Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
29,687,135
-
Share change
-
-2,781,532
-
Total reported value
-
$171,598,587
-
Put/Call ratio
-
189%
-
Price per share
-
$5.78
-
Number of holders
-
116
-
Value change
-
-$27,971,318
-
Number of buys
-
54
-
Number of sells
-
60
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2022
As of 31 Dec 2022 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,687,135 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, BlackRock Inc., VANGUARD GROUP INC, 683 Capital Management, LLC, BAILLIE GIFFORD & CO, D. E. Shaw & Co., Inc., KPS Global Asset Management UK Ltd, WORLDLY PARTNERS MANAGEMENT, LLC, General Equity Holdings LP, and Alua Capital Management LP.
This table shows 117 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.